Physician profile
Robert Russell
NPI 1386671543
$2,684.48
in general payments reported to CMS, 2019-2025
22 companies · $416 in 2025
The $416 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $279 · 2021: $288 · 2022: $407 · 2023: $530 · 2024: $318 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,264.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $707.94 | 2019-2025 | Orilissa, Lo Loestrin Fe |
| Lupin INC. | $480.46 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $330.35 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $217.13 | 2020-2024 | |
| Evofem Biosciences, INC. | $179.11 | 2021-2025 | Phexxi, Solosec, Phexx |
| Cumberland Pharmaceuticals, INC. | $114.55 | 2020-2023 | Caldolor |
| Astellas Pharma US INC | $110.74 | 2023-2025 | Veozah |
| Myovant Sciences INC. | $107.40 | 2022 | |
| Axsome Therapeutics, INC. | $73.97 | 2025 | Auvelity |
| Amag Pharmaceuticals, INC. | $59.03 | 2019-2021 | |
| Exeltis, USA INC. | $57.91 | 2024 | Slynd |
| Organon LLC | $40.99 | 2023-2024 | Nexplanon |
| Exact Sciences Corporation | $32.89 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Baxter Healthcare | $28.79 | 2025 | Perclot |
| Merck Sharp & Dohme LLC | $27.46 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $27.04 | 2021-2023 | Balcoltra |
| Smith+Nephew, INC. | $18.68 | 2022 | |
| Hologic Sales and Service, LLC | $17.48 | 2025 | Novasure |
| Sage Therapeutics, LLC | $17.18 | 2025 | Zurzuvae |
| Medtronic USA, INC. | $12.46 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.72 | 2019 | |
| Roche Diagnostics Corporation | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.